Hong Kong stock anomaly | Beihai Kangcheng (01228.HK) rises again by more than 19%, with a cumulative increase of over 20 times this year. Three products pass the initial review of the commercial insurance new drug list.

According to the Securities Times APP, North Sea Kangcheng (01228.HK) has risen by over 19% again, with a total increase of over 2000% so far this year. As of the publication of this article, the stock has gone up by 15.51%, reaching 2.83 Hong Kong dollars, with a trading volume of 66.9149 million Hong Kong dollars.